Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 28

1.

Incidental Diagnosis of Parathyroid Lesions by Preoperative Use of Next-Generation Molecular Testing.

Bo W, Schoedel KE, Carty SE, Radkay LA, Ohori NP, Nikiforov YE, Nikiforova MN, Yip L.

World J Surg. 2018 Feb 22. doi: 10.1007/s00268-018-4548-3. [Epub ahead of print]

PMID:
29470700
2.

The influence of the noninvasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP) resection diagnosis on the false-positive thyroid cytology rate relates to quality assurance thresholds and the application of NIFTP criteria.

Ohori NP, Wolfe J, Carty SE, Yip L, LeBeau SO, Berg AN, Schoedel KE, Nikiforov YE, Seethala RR.

Cancer Cytopathol. 2017 Sep;125(9):692-700. doi: 10.1002/cncy.21892. Epub 2017 Jul 5.

PMID:
28678437
3.

Changes in Resident Graduate Characteristics in a Large Pathology Training Program, 1994 to 2013.

Ohori NP, Radkay LA, Macpherson TA, Yousem SA, Schoedel KE.

Acad Pathol. 2016 Apr 19;3:2374289516643543. doi: 10.1177/2374289516643543. eCollection 2016 Jan-Dec.

4.

Significance of what is not sampled: Characteristics of thyroid nonmicrocarcinomas (>1.0 cm) that were not targeted.

Schoedel KE, Wolfe J, Hodak SP, Lebeau SO, Yip L, Carty SE, Nikiforova MN, Nikiforov YE, Ohori NP.

Cancer Cytopathol. 2015 Nov;123(11):678-83. doi: 10.1002/cncy.21603. Epub 2015 Aug 4.

5.

Thyroid nodules with KRAS mutations are different from nodules with NRAS and HRAS mutations with regard to cytopathologic and histopathologic outcome characteristics.

Radkay LA, Chiosea SI, Seethala RR, Hodak SP, LeBeau SO, Yip L, McCoy KL, Carty SE, Schoedel KE, Nikiforova MN, Nikiforov YE, Ohori NP.

Cancer Cytopathol. 2014 Dec;122(12):873-82. doi: 10.1002/cncy.21474. Epub 2014 Aug 12.

6.

Ancillary Studies in Thyroid Cytopathology.

Ohori NP, Schoedel KE.

Surg Pathol Clin. 2014 Mar;7(1):47-60. doi: 10.1016/j.path.2013.10.001. Epub 2013 Nov 25. Review.

PMID:
26839268
7.

"Colloid-rich" follicular neoplasm/suspicious for follicular neoplasm thyroid fine-needle aspiration specimens: cytologic, histologic, and molecular basis for considering an alternate view.

Ohori NP, Wolfe J, Hodak SP, LeBeau SO, Yip L, Carty SE, Duvvuri U, Schoedel KE, Nikiforova MN, Nikiforov YE.

Cancer Cytopathol. 2013 Dec;121(12):718-28. doi: 10.1002/cncy.21333. Epub 2013 Jul 23. Erratum in: Cancer Cytopathol. 2014 Dec;122(12):921.

8.

Integration of KRAS testing in the diagnosis of pancreatic cystic lesions: a clinical experience of 618 pancreatic cysts.

Nikiforova MN, Khalid A, Fasanella KE, McGrath KM, Brand RE, Chennat JS, Slivka A, Zeh HJ, Zureikat AH, Krasinskas AM, Ohori NP, Schoedel KE, Navina S, Mantha GS, Pai RK, Singhi AD.

Mod Pathol. 2013 Nov;26(11):1478-87. doi: 10.1038/modpathol.2013.91. Epub 2013 Jun 7.

9.

BRAF mutation detection in indeterminate thyroid cytology specimens: underlying cytologic, molecular, and pathologic characteristics of papillary thyroid carcinoma.

Ohori NP, Singhal R, Nikiforova MN, Yip L, Schoedel KE, Coyne C, McCoy KL, LeBeau SO, Hodak SP, Carty SE, Nikiforov YE.

Cancer Cytopathol. 2013 Apr;121(4):197-205. doi: 10.1002/cncy.21229. Epub 2012 Aug 7.

11.

Selective screening for nongynecologic cytology specimens: modifying the screening process for improved efficiency and practice.

Marks-Jones DA, Sutkowski BA, Schoedel KE, Ohori NP.

Diagn Cytopathol. 2011 Oct;39(10):717-22. doi: 10.1002/dc.21449. Epub 2010 Nov 2.

PMID:
21919214
12.

Thyroid cytology: challenges in the pursuit of low-grade malignancies.

Ohori NP, Schoedel KE.

Radiol Clin North Am. 2011 May;49(3):435-51, v-vi. doi: 10.1016/j.rcl.2011.02.005. Review.

PMID:
21569903
13.

DNA mutational differences in cytological specimens from pancreatic cancer and cholangiocarcinoma.

Fasanella KE, Krasinskas A, Schoedel KE, Sasatomi E, Slivka A, Whitcomb DC, Sanders M, Nodit L, Raab S, McGrath KM, Ohori NP, Khalid A.

Pancreatology. 2010;10(4):429-33. doi: 10.1159/000318807. Epub 2010 Aug 19.

PMID:
20720444
14.

Contribution of molecular testing to thyroid fine-needle aspiration cytology of "follicular lesion of undetermined significance/atypia of undetermined significance".

Ohori NP, Nikiforova MN, Schoedel KE, LeBeau SO, Hodak SP, Seethala RR, Carty SE, Ogilvie JB, Yip L, Nikiforov YE.

Cancer Cytopathol. 2010 Feb 25;118(1):17-23. doi: 10.1002/cncy.20063.

15.

EUS-guided FNA diagnosis of primary splenic lymphoma.

El Hajj II, Khalid A, Schoedel KE, Abu-Elmagd KM, McGrath KM, Fasanella KE.

Gastrointest Endosc. 2009 Mar;69(3 Pt 1):585-8. doi: 10.1016/j.gie.2008.04.058. Epub 2008 Nov 13. No abstract available.

PMID:
19012888
16.

Ultrasound-guided biopsy of the thyroid: a comparison of technique with respect to diagnostic accuracy.

Schoedel KE, Tublin ME, Pealer K, Ohori NP.

Diagn Cytopathol. 2008 Nov;36(11):787-9. doi: 10.1002/dc.20896.

PMID:
18831012
17.

Endoscopic ultrasound-guided fine needle aspirate microsatellite loss analysis and pancreatic endocrine tumor outcome.

Nodit L, McGrath KM, Zahid M, Jani N, Schoedel KE, Ohori NP, Carty S, Finkelstein S, Khalid A.

Clin Gastroenterol Hepatol. 2006 Dec;4(12):1474-8. Epub 2006 Sep 25.

PMID:
16996803
18.
19.

Clonorchis sinensis-associated cholangiocarcinoma: a case report and review of the literature.

Papachristou GI, Schoedel KE, Ramanathan R, Rabinovitz M.

Dig Dis Sci. 2005 Nov;50(11):2159-62. Review. No abstract available.

PMID:
16240232
20.

Supplemental Content

Loading ...
Support Center